Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

  1. Manso, L.
  2. Hernando, C.
  3. Galán, M.
  4. Oliveira, M.
  5. Cabrera, M.A.
  6. Bratos, R.
  7. Rodríguez, C.A.
  8. Ruiz-Borrego, M.
  9. Blanch, S.
  10. Llombart-Cussac, A.
  11. Delgado-Mingorance, J.I.
  12. Álvarez-Busto, I.
  13. Gallegos, I.
  14. González-Cortijo, L.
  15. Morales, S.
  16. Aguirre, E.
  17. Hernando, B.A.
  18. Ballesteros, A.
  19. Alés-Martínez, J.E.
  20. Reboredo, C.
  21. Oltra, A.
  22. González-Cao, M.
  23. Santisteban, M.
  24. Malón, D.
  25. Echeverría, I.
  26. García-Garre, E.
  27. Vega, E.
  28. Servitja, S.
  29. Andrés, R.
  30. Robles, C.E.
  31. López, R.
  32. Galve, E.
  33. Echarri, M.J.
  34. Legeren, M.
  35. Moreno, F.
  36. Montrer des auteurs +
Revue:
Breast

ISSN: 1532-3080,  0960-9776

Année de publication: 2020

Volumen: 54

Pages: 286-292

Type: Article

DOI: 10.1016/J.BREAST.2020.11.005 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus